DK315884A - Fremgangsmaade til percutan anvendelse af fysiologisk aktive midler under anvendelse af et alkohol-hjaelpestof og et oploesningsmiddel - Google Patents

Fremgangsmaade til percutan anvendelse af fysiologisk aktive midler under anvendelse af et alkohol-hjaelpestof og et oploesningsmiddel Download PDF

Info

Publication number
DK315884A
DK315884A DK315884A DK315884A DK315884A DK 315884 A DK315884 A DK 315884A DK 315884 A DK315884 A DK 315884A DK 315884 A DK315884 A DK 315884A DK 315884 A DK315884 A DK 315884A
Authority
DK
Denmark
Prior art keywords
percutan
solvents
procedure
active agents
physiologically active
Prior art date
Application number
DK315884A
Other languages
Danish (da)
English (en)
Other versions
DK315884D0 (da
Inventor
Kenichiro Saito
Jorge Heller
Wilfred A Skinner
Original Assignee
Nitto Electric Ind Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Ind Co filed Critical Nitto Electric Ind Co
Publication of DK315884D0 publication Critical patent/DK315884D0/da
Publication of DK315884A publication Critical patent/DK315884A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK315884A 1983-07-01 1984-06-28 Fremgangsmaade til percutan anvendelse af fysiologisk aktive midler under anvendelse af et alkohol-hjaelpestof og et oploesningsmiddel DK315884A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/510,133 US4590190A (en) 1983-07-01 1983-07-01 Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent

Publications (2)

Publication Number Publication Date
DK315884D0 DK315884D0 (da) 1984-06-28
DK315884A true DK315884A (da) 1985-01-02

Family

ID=24029504

Family Applications (1)

Application Number Title Priority Date Filing Date
DK315884A DK315884A (da) 1983-07-01 1984-06-28 Fremgangsmaade til percutan anvendelse af fysiologisk aktive midler under anvendelse af et alkohol-hjaelpestof og et oploesningsmiddel

Country Status (10)

Country Link
US (1) US4590190A (sv)
JP (1) JPS6013721A (sv)
CA (1) CA1228027A (sv)
CH (1) CH658994A5 (sv)
DE (1) DE3424057C3 (sv)
DK (1) DK315884A (sv)
FR (1) FR2548025B1 (sv)
GB (1) GB2142237B (sv)
NL (1) NL8402046A (sv)
SE (1) SE459712B (sv)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
EP0248885B1 (en) * 1985-12-04 1992-08-05 HSIEH, Dean Transdermal delivery of drugs
US4855132A (en) * 1986-02-25 1989-08-08 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4764364A (en) * 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
CH679119A5 (sv) * 1988-05-13 1991-12-31 Sandoz Ag
JPH02104531A (ja) * 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
US5246949A (en) * 1989-12-06 1993-09-21 Sansho Co., Ltd. Preparation for endermism containing dopamine derivatives
JPH03236317A (ja) * 1989-12-06 1991-10-22 Sansei Seiyaku Kk ドパミン誘導体含有経皮用製剤
AU2514292A (en) * 1991-08-27 1993-03-16 Cygnus Therapeutic Systems Transdermal formulations for administering prazosin
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
AU6410494A (en) * 1993-03-17 1994-10-11 Alza Corporation Device for the transdermal administration of alprazolam
JP3688293B2 (ja) * 1993-09-29 2005-08-24 アルザ・コーポレーション モノグリセリド／乳酸エステル透過促進剤
ATE228834T1 (de) * 1994-09-30 2002-12-15 Oreal Verwendung von einem agonisten eines mit einem chloridkanal assozierten rezeptors zur behandlung von hautfalten
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
DE19725615A1 (de) * 1997-06-17 1998-12-24 Permamed Ag Zur topischen Applikation bestimmte Diclofenac-Lösung
US6491575B2 (en) * 1997-07-03 2002-12-10 Andreas Sarantitis Tool for the removal of paint-like materials from work surfaces
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
ATE377048T1 (de) * 2000-09-06 2007-11-15 Ap Pharma Inc Abbaubare polyacetal-polymere
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US6828278B2 (en) * 2003-03-24 2004-12-07 E.I. Du Pont De Nemours And Company Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with arly amines
US20040192938A1 (en) * 2003-03-24 2004-09-30 Manzer Leo Ernest Production of 5-mehyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive of levulinic acid esters with aryl and alkyl amines
US6855731B2 (en) * 2003-03-24 2005-02-15 E. I. Du Pont De Nemours And Company Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with nitro compounds
US6818593B2 (en) * 2003-03-24 2004-11-16 E. I. Du Pont De Nemours And Company Production of 5-Methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds
US6900337B2 (en) * 2003-03-24 2005-05-31 E. I. Du Pont De Nemours And Company Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid
US6828277B2 (en) * 2003-03-24 2004-12-07 E. I. Du Pont De Nemours And Company Production of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds
US20050158329A1 (en) * 2004-01-21 2005-07-21 Ghosh Swapan K. Novel phytol derived immunoadjuvants and their use in vaccine formulations
EP1917976B1 (en) * 2005-08-01 2011-03-16 Hisamitsu Pharmaceutical Co. Inc. Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration
RU2011111206A (ru) * 2008-10-31 2012-12-10 Моберг Дерма Аб Композиции для местного применения, содержащие комбинацию по меньшей мере двух агентов, усиливающих проникновение
JP6114401B2 (ja) 2013-10-31 2017-04-12 久光製薬株式会社 アジュバント組成物、これを含むアジュバント製剤、及びキット

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227617B (de) * 1961-07-20 1966-10-27 Dr Med Friedrich Meyer Penetrationsvermittler
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
SE7506731L (sv) * 1974-07-01 1976-01-02 Merck & Co Inc Komposition for behandling av akne.
DE2528516A1 (de) * 1974-07-05 1976-01-22 Sandoz Ag Neue galenische zubereitung
GB1504302A (en) * 1974-08-23 1978-03-15 Fisons Ltd Sedative method and composition
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
JPS52148614A (en) * 1976-06-04 1977-12-10 Masao Yonemushi Production of additive for skin medicine
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
AU521982B2 (en) * 1978-06-16 1982-05-13 Phares Pharmaceutical Research N.V. Pharmaceuticals with urea incuusion compounds
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone

Also Published As

Publication number Publication date
CA1228027A (en) 1987-10-13
CH658994A5 (de) 1986-12-31
GB2142237B (en) 1987-09-23
GB2142237A (en) 1985-01-16
DK315884D0 (da) 1984-06-28
DE3424057C2 (de) 1986-05-28
GB8415975D0 (en) 1984-07-25
FR2548025B1 (fr) 1988-04-29
JPS645579B2 (sv) 1989-01-31
FR2548025A1 (fr) 1985-01-04
SE459712B (sv) 1989-07-31
DE3424057A1 (de) 1985-01-10
US4590190A (en) 1986-05-20
SE8403487D0 (sv) 1984-06-29
JPS6013721A (ja) 1985-01-24
NL8402046A (nl) 1985-02-01
SE8403487L (sv) 1985-01-02
DE3424057C3 (de) 1992-05-07

Similar Documents

Publication Publication Date Title
DK315884D0 (da) Fremgangsmaade til percutan anvendelse af fysiologisk aktive midler under anvendelse af et alkohol-hjaelpestof og et oploesningsmiddel
DK163562C (da) Indretning til intravaginal applikation af et aktivt middel for dyr og apparat til indfoering af indretningen
DK294685A (da) Apparat og fremgangsmaade til pulseret administration af vaekstfremmende midler
DK0500807T3 (da) Præparat og fremgangsmåde til befugtning af væv
DK166088D0 (da) Fremgangsmaade til fremstilling af kvaternaere esteraminer og anvendelse heraf
DK179187D0 (da) Apparat og fremgangsmaade til hoestning af afgroeder
DK368579A (da) Fremgangsmaade til fremstilling af et antistofholdigt immunoglobulinpraeparat til intravenoes indgift og deraf fremstillede praeparater
DK80184A (da) Fremgangsmaade og kredsloeb til behandling af impulser
DK239984D0 (da) Fremgangsmaade til perkutan indgivning af fysiologisk aktive midler
DK164699C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive aminopropanolderivater og fysiologisk acceptable syreadditionssalte heraf
DK166780C (da) Optisk aktivt borankompleks og fremgangsmaade til fremstilling af optisk aktive alkoholderivater under anvendelse heraf
DK315984D0 (da) Fremgangsmaade til percutan anvendelse af fysiologisk aktive midler under anvendelse af et hjaelpestof, et oploesningsmiddel og en diol-moderator
DK618787D0 (da) Fremgangsmaade og apparat til lodret fremstilling af saakaldte sandwich-konstruktionselementer
DK360379A (da) Peptid-enzym-konjugat og fremgangsmaade til enzym-immunanalyse af pankreatisk glucagon
DK159296C (da) Fremgangsmaade og proeveudstyr til diagnosticering af reumatologiske sygdomme
DK461777A (da) Fremgangsmaade og stillads til behandling af overliggende konstruktioner
DK154327C (da) Fremgangsmaade til isolering og rensning af immunologisk aktivt polyribosylribitolphosphat
DK28290D0 (da) Fremgangmaade og apparat til rensning af affedtningsoploesninger
DK139379A (da) Fremgangsmaade og apparat til dekontaminering af brugsgenstande
DK541986A (da) Apparat og fremgangsmaade til udsproejtning af kemikalier over afgroeder
DK356486D0 (da) Apparat og fremgangsmaade til vaadbehandling af tekstiler
DK257687D0 (da) Fremgangsmaade og middel til regulering af fertilitet hos svin
DK436887A (da) Fremgangsmaade til fremstilling af triazol-tetrahydrofuran-derivater og mellemprodukter til anvendelse herved
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK153932C (da) Fremgangsmaade og anlaeg til enkeltvis emballering af fjerkrae i poser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment